15.02.2013 Views

world cancer report - iarc

world cancer report - iarc

world cancer report - iarc

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

A Injection into transformed cell<br />

B<br />

Phase-contrast micrographs<br />

Fig. 3.31 Selective gap junctional communication: cells transformed by a chemical carcinogen (spindleshaped<br />

and criss-crossed) communicate among themselves, but not with their surrounding non-transformed<br />

counterparts. When a gap junction-diffusible fluorescent dye is microinjected into a single cell<br />

(marked with star) of a transformed focus there is communication between transformed cells but not with<br />

the surrounding non-transformed cells (A, B). Injection of the dye into a non-transformed cell which is<br />

located near a transformed focus results in communication between non-transformed cells, but not with<br />

transformed cells (C, D).<br />

110 Mechanisms of tumour development<br />

Fluorescence micrographs<br />

C Injection into non-transformed cell<br />

D<br />

Transfected cells<br />

carrying the HSV-tk gene<br />

Tumour cell population<br />

Cells carrying the tk gene are<br />

killed by the toxic phosphorylated<br />

GCV (GCV-P) they produce<br />

GCV-P<br />

GCV-P<br />

Ganciclovir<br />

(GCV)<br />

junctional intercellular communication<br />

during carcinogenesis and tumour progression.<br />

Another line of evidence, that implies a<br />

causal role for blockage of intercellular<br />

communication in carcinogenesis, is that<br />

agents or genes involved in carcinogenesis<br />

have been shown to modulate gap junctional<br />

intercellular communication. The<br />

mouse skin tumour-promoting agent 12-Otetradecanoylphorbol<br />

13-acetate (TPA)<br />

inhibits gap junctional intercellular communication.<br />

Many other tumour-promoting<br />

agents inhibit gap junctional intercellular<br />

communication [9]. In addition to such<br />

chemicals, other tumour-promoting stimuli,<br />

such as partial hepatectomy and skin<br />

wounding, have been demonstrated to<br />

inhibit gap junctional intercellular communication.<br />

Activation of various oncogenes,<br />

including those which encode src, SV-40 T<br />

antigen, c-erbB2/neu, raf, fps and ras, also<br />

results in inhibition of gap junctional intercellular<br />

communication. Conversely, some<br />

chemopreventive agents enhance gap junctional<br />

intercellular communication [10].<br />

No bystander<br />

effect<br />

Bystander<br />

effect<br />

GCV-P cannot pass through<br />

the cell membrane<br />

Movement of GVC-P<br />

from cytoplasm to<br />

cytoplasm in gap<br />

junctions<br />

Fig. 3.32 Role of cell-cell interaction in gene therapy. In a tumour cell population, only a few cells can be reached by vectors carrying the HSV-tk gene.<br />

Expression of the tk gene (orange) makes these cells sensitive to ganciclovir: they produce phosphorylated ganciclovir, which is toxic. As phosphorylated ganciclovir<br />

cannot pass through the cell membrane, theoretically only cells expressing the tk gene will die as a result of ganciclovir treatment. Transmembrane diffusion<br />

of phosphorylated ganciclovir from cytoplasm to cytoplasm can induce a bystander effect sufficient to eradicate a tumour cell population, even if only a<br />

few cells express the tk gene [13].

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!